Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania Completed Phase 3 Trials for Valproic acid (DB00313)

IndicationStatusPhase
DBCOND0034544 (Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00278772Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomania or Mild ManiaTreatment